.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Cerilliant
Cipla
McKesson
Johnson and Johnson
McKinsey
Chubb
Colorcon
Teva

Generated: September 20, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Taxol derivatives, their preparation and pharmaceutical compositions containing them
Abstract:Taxol derivatives of formula ##STR1## in which R represents hydrogen or acetyl, one of R.sub.1 or R.sub.2 represents hydroxy and the other represents tert-butoxycarbonylamino and their isomers are useful antitumor agents.
Inventor(s): Colin; Michel (Thoiry, FR), Guenard; Daniel (Montrouge, FR), Gueritte-Voegelein; Francoise (Paris, FR), Potier; Pierre (Paris, FR)
Assignee: Rhone-Poulenc Sante (Courbevoie, FR)
Application Number:07/073,156
Patent Claims: 1. A taxol derivative of formula: ##STR7## in which R represents hydrogen or acetyl and one of R.sub.1 and R.sub.2 represents hydroxy and the other represents tert-butoxycarbonylamino, and the stereoisomeric forms thereof and their mixtures.

2. A taxol derivative according to claim 1, in which R is hydrogen, R.sub.1 is hydroxy and R.sub.2 is tert-butoxycarbonylamino, and having the 2'R, 3'S configuration.

3. A taxol derivative according to claim 1, in which R is hydrogen, R.sub.1 is hydroxy, and R.sub.2 is tert-butoxycarbonylamino, and having the 2'S, 3'R configuration.

4. A taxol derivative according to claim 1, in which R is hydrogen, R.sub.1 is tert-butoxycarbonylamino, and R.sub.2 is hydroxy, and having the 2'R, 3'S configuration.

5. A taxol derivative according to claim 1, in which R is hydrogen, R.sub.1 is tert-butoxycarbonylamino, and R.sub.2 is hydroxy and having the 2'S, 3'R configuration.

6. A pharmaceutical composition which contains a taxol derivative as claimed in claim 1 combined with one or more pharmaceutically acceptable, inert or physiologically active diluents or adjuvants.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
AstraZeneca
Chubb
McKesson
Harvard Business School
Argus Health
Medtronic
Express Scripts
Dow
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot